PMID- 21457185
OWN - NLM
STAT- MEDLINE
DCOM- 20110922
LR  - 20240109
IS  - 1600-9657 (Electronic)
IS  - 1600-4469 (Linking)
VI  - 27
IP  - 3
DP  - 2011 Jun
TI  - Short-term antimicrobial properties of mineral trioxide aggregate with 
      incorporated silver-zeolite.
PG  - 189-94
LID - 10.1111/j.1600-9657.2011.00986.x [doi]
AB  - The purpose of this in vitro study was to determine whether adding silver-zeolite 
      (SZ) to mineral trioxide aggregate (MTA) would enhance the antimicrobial activity 
      of MTA against Staphylococcus aureus (ATCC #25923), Enterococcus faecalis (ATCC 
      #29212), Escherichia coli (ATCC#25922), Pseudomonas aeruginosa (ATCC #27853), 
      Candida albicans (ATCC #90028), Porphyromonas gingivalis (ATCC #33277), 
      Actinomyces israelii (ATCC #12102), and Prevotella intermedia (ATCC# 15032). SZ 
      was added at 0.2% and 2% mass fraction concentration to MTA powder. The control 
      group was MTA powder with no SZ. The antimicrobial effect test was accomplished 
      by placing freshly mixed MTA specimens on agar plates inoculated with 
      microorganisms and comparing the zones of inhibition at 24, 48, and 72 h. The 
      amounts of silver ion release from MTA specimens were measured with atomic 
      absorption spectrophotometry at 10-min, 24-, 48-, and 72-h periods. The pH of MTA 
      specimens was measured with a pH meter at 10-min, 24-, 48-, and 72-h periods. MTA 
      with 2% and 0.2% SZ specimens showed inhibitory effects on some microorganisms at 
      all time periods, whereas no antimicrobial activity showed for P. intermedia and 
      A. israelii. MTA without SZ inhibited C. albicans, E. Coli, and P. intermedia. 
      The highest silver release was detected in 2% SZ MTA at 24 h. The incorporation 
      of SZ may enhance the antimicrobial activity of MTA.
CI  - (c) 2011 John Wiley & Sons A/S.
FAU - Odabas, Mesut E
AU  - Odabas ME
AD  - Departments of Pediatric Dentistry Microbiology, Faculty of Dentistry, University 
      of Gazi Department of Chemical Engineering, Faculty of Engineering, University of 
      Middle East Technical, Ankara, Turkey. mesut@gazi.edu.tr
FAU - Cinar, Cagdas
AU  - Cinar C
FAU - Akca, Gulcin
AU  - Akca G
FAU - Araz, Ibrahim
AU  - Araz I
FAU - Ulusu, Tezer
AU  - Ulusu T
FAU - Yucel, Hayrettin
AU  - Yucel H
LA  - eng
PT  - Comparative Study
PT  - Journal Article
DEP - 20110404
PL  - Denmark
TA  - Dent Traumatol
JT  - Dental traumatology : official publication of International Association for 
      Dental Traumatology
JID - 101091305
RN  - 0 (Aluminum Compounds)
RN  - 0 (Anti-Infective Agents)
RN  - 0 (Calcium Compounds)
RN  - 0 (Culture Media)
RN  - 0 (Drug Combinations)
RN  - 0 (Oxides)
RN  - 0 (Root Canal Filling Materials)
RN  - 0 (Silicates)
RN  - 0 (mineral trioxide aggregate)
RN  - 1318-02-1 (Zeolites)
RN  - 3M4G523W1G (Silver)
MH  - Actinomyces/drug effects
MH  - Aluminum Compounds/chemistry/*pharmacology
MH  - Anti-Infective Agents/*pharmacology
MH  - Calcium Compounds/chemistry/*pharmacology
MH  - Candida albicans/drug effects
MH  - Culture Media
MH  - Diffusion
MH  - Drug Combinations
MH  - Enterococcus faecalis/drug effects
MH  - Escherichia coli/drug effects
MH  - Humans
MH  - Hydrogen-Ion Concentration
MH  - Materials Testing
MH  - Oxides/chemistry/*pharmacology
MH  - Porphyromonas gingivalis/drug effects
MH  - Prevotella intermedia/drug effects
MH  - Pseudomonas aeruginosa/drug effects
MH  - Root Canal Filling Materials/chemistry/*pharmacology
MH  - Silicates/chemistry/*pharmacology
MH  - Silver/chemistry/*pharmacology
MH  - Spectrophotometry, Atomic
MH  - Staphylococcus aureus/drug effects
MH  - Time Factors
MH  - Zeolites/*pharmacology
EDAT- 2011/04/05 06:00
MHDA- 2011/09/23 06:00
CRDT- 2011/04/05 06:00
PHST- 2011/04/05 06:00 [entrez]
PHST- 2011/04/05 06:00 [pubmed]
PHST- 2011/09/23 06:00 [medline]
AID - 10.1111/j.1600-9657.2011.00986.x [doi]
PST - ppublish
SO  - Dent Traumatol. 2011 Jun;27(3):189-94. doi: 10.1111/j.1600-9657.2011.00986.x. 
      Epub 2011 Apr 4.